SavedAdd your journal

Journals / Türk Osteoporoz Dergisi / 2013 / Cilt: 19 - Sayı: 1

Hemodiyaliz hastalarında renal osteodistrofinin radyolojik ve biyokimyasal yöntemlerle değerlendirilmesi

The evaluation of renal osteodystrophy in patients on hemodialysis by biochemical and radiological methods

Ece ÜNLÜ
Sibel MANDIROĞLU
Deniz AYLI
Pages
7–11
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were signicant differences between case and control groups in all biochemical parameters, except calcium levels (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We planned this study in order to evaluate the radiological and biochemical parameters that may be useful in the early diagnosis of renal osteodystrophy in the patients with chronic renal failure, prospectively.
📊
Key Findings & Data:Meterial and Methods: In this study, 50 cases on hemodialysis due to chronic renal failure were included and 50 cases without renal and bone pathology were included as control group.
💡
Conclusion & Impact:There were signicant differences between case and control groups in all biochemical parameters, except calcium levels (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: We planned this study in order to evaluate the radiological and biochemical parameters that may be useful in the early diagnosis of renal osteodystrophy in the patients with chronic renal failure, prospectively. Meterial and Methods: In this study, 50 cases on hemodialysis due to chronic renal failure were included and 50 cases without renal and bone pathology were included as control group. Serum levels of calcium, phosphate, alkalen phosphatase, βm, osteocalcin (BGP) and intact parathormon (iPTH) were measured. Right hand graphies of both case and control groups were taken by magnifying techniques. Bone mineral densities (BMD) of lumbar vertebra and femur neck were calculated by DEXA method. Results: The average disease duration and the average of duration of hemodialysis of cases were 8.38±5.61years and 6.9±4.01years, respectively. There were signicant differences between case and control groups in all biochemical parameters, except calcium levels (p

Özet

Amaç: Bu çalışmada kronik böbrek yetmezliği olan olgularda renal osteodistronin erken tanısında faydalı olabilecek radyolojik ve biyokimyasal parametreleri prospektif olarak araştırmayı planladık. Gereç ve Yöntem: Kronik böbrek yetmezliği nedeni ile hemodiyalize giren 50 olgu ve dahil edildi. Böbrek problemi ve kemik hastalığı olmayan 50 olgu kontrol grubu olarak çalışmaya dahil edildi. Serum kalsiyum, fosfor, alkalen fosfataz,β−microglobulin (βm), osteokalsin (BGP), intact parathormon (iPTH) seviyeleri ölçüldü.Her iki grupta sağ el graleri magniye teknikle çekildi. Lomber vertebra ve femur boyun kemik mineral yoğunluğu (KMY) DEXA yöntemi ile ölçüldü. Bulgular: Olgularımızın ortalama hastalık süresi 8,38±5,61 yıl, diyalize girme süresi 6,9±4,01 yıldı. Kalsiyum dışındaki bütün biyokimyasal parametlerde olgu ve kontrol grubumuz arasında önemli derecede fark mevcuttu (p

🔖

Cite This Article

ÜNLÜ, E., MANDIROĞLU, S., AYLI, D. (2022). Hemodiyaliz hastalarında renal osteodistrofinin radyolojik ve biyokimyasal yöntemlerle değerlendirilmesi. Türk Osteoporoz Dergisi, Cilt: 19 - Sayı: 1, 7–11. https://ajindex.com/articles/639860

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Lach F, Bover J. Renal Osteodystrophy. In: Brenner BM, Rector FC, editors. Textbook of Nephrology 1996; 2: 2187-2254
  2. Brenner BM, Lazarus M. Chronic Renal Failure. In: Isebocher K, Braunwarld E, editors. Harrison’s Principles of Internal Medicine. McGraw-Hill 1994;2:1274-81
  3. Gonzalez EA, Martin KJ. Renal osteodystrophy: pathogenesis and management. Nephrol Dial Transplant 1995;10:13-21
  4. Ott SM. Bone histomorphometry in renal osteodystrophy. Semin Nephrol 2009;29: 122-32
  5. Gal-Moscovici A, Popovtzer MM. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels. Clin Nephrol 2005;63:284-9
  6. Tsukamoto Y. Kidney and bone update: the 5-year history and future of CKD-MBD. Bone biopsy and histomorphometrical analysis. Clin Calcium 2012;22:1019-24
  7. Seyrek N. The following up and management of renal osteodystrophy in dialysis patients. Turkiye Klinikleri J Int Med Sci 2006;2:55-62
  8. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:51-2
  9. Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, et al. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 2004;43:558-65
  10. Asaka M, Iida H, Entani C, Fujita M, Izumino K, Takata M, et al: Total and regional bone mineral density by dual photon absorptiometry in patients on maintenance hemodialysis. Clinical Nephrol 1992;38:149-53
  11. Rizzoli R, Slosman D, Bonjour JP. The role of dual energy X-ray absorptiometry of lumbar spine and proximal femur in the diagnosis and follow-up of osteoporosis. Am J Med 1995;98:33-6
  12. Roschger P, Paschalis EP, Fratzl P, Klaushofer K. Bone mineralization density distribution in health and disease. Bone 2008;42:456-66
  13. Miller PD. Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction. Curr Osteoporo Rep 2005;3:103-10
  14. Miller PD, Hochberg MC, Wehren LE, Ross PD, Wasnich RD. How useful are measures of BMD and bone turnover? Curr Med Res Opin 2005;21:545-54
  15. Rahimian M, Sami R, Behzad F. Evaluation of secondary hyperparathyroidism in patients undergoing hemodialysis. Saudi J Kidney Dis Transpl 2008;19:116-9
  16. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Denition, evaluation, and classication of renal osteodystrophy: a position statement from Kidney Disease: Im